Destiny Pharma PLC said Nigel Rudd is stepping down as chairman and a member of its board Dec. 31.
Rudd will be replaced by Nick Rodgers, a nonexecutive director of Destiny Pharma, in the chairman role.
Brighton, U.K.-based Destiny Pharma develops and sells medicines for infectious diseases.